# Medtronic Neuromodulation

- Location (FDA's records): Minneapolis
- FDA decisions: 5 (1984–2025): 1 De Novo grant and 4 original PMA approvals
- Product codes: EZW (1), QPT (1), QQC (1), LGW (1), QON (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 3 (0 its own)
- Recalls linked to its devices: 14 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Turing Medical Technologies, Inc.: 1 (https://510kreport.com/company/turing-medical-technologies)
- Medtronic Neurological: 1 (https://510kreport.com/company/medtronic-neurological)
- Brainlab AG: 1 (https://510kreport.com/company/brainlab)

## Its most-cited devices
- DEN210003: SureTune4 Software (2021), cited by 2
- P970004: Medtronic Interstim Therapy System for Urinary Control (1997), cited by 1

## Recent decisions
- P240011: Medtronic Altaviva System (Sep 18, 2025)
- DEN210003: SureTune4 Software (Aug 23, 2021)
- P080025: Medtronic Interstim Sacral Nerve Stimulation Therapy System (Mar 14, 2011)
- P970004: Medtronic Interstim Therapy System for Urinary Control (Sep 29, 1997)
- P840001: Itrel (R) Totally Implantable Spinal Cord Stim. Sys (Nov 30, 1984)

Source page: https://510kreport.com/company/medtronic-neuromodulation